Clinical Trial Update: Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of simtuzumab in adults with primary myelofibrosis or post polycythemia vera/post essential thrombocythemia myel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Simtuzumab (simtuzumab)

Snippet

Sponsor: Gilead Sciences | Conditions: Myelofibrosis | Phase 2 | Status: COMPLETED | Results posted: 2020-07-01